Muramatsu K, Doi K, Kawai S
Department of Orthopaedic Surgery, Yamaguchi University School of Medicine, Japan.
J Hand Surg Am. 1999 May;24(3):586-93. doi: 10.1053/jhsu.1999.0586.
The immunosuppressive effect of combined therapy using FK-506 and 15-deoxyspergualin was investigated in rat limb allotransplantation. The right hindlimb of an inbred Dark Agouti rat (RT1a) was transplanted to a Lewis rat (RT1l) and observed for 120 days. Eighty-eight transplantations were performed. Rejection of the grafts was evaluated histologically as well as macroscopically. A pathologic grading system was used to rate the severity of rejection. Limb survival time in Lewis rats receiving FK-506 therapy for days was significantly prolonged by combined therapy with 15-deoxyspergualin. Histologic study showed practically no rejection in all the graft-composing tissues except the skin and bone marrow, in which there was rejection. These results suggest that tissues like bone, cartilage, and muscle may survive transplantation with short-term combination FK-506 and 15-deoxyspergualin therapy even after withdrawal of both agents.
在大鼠肢体同种异体移植中研究了使用FK-506和15-去氧精胍菌素联合治疗的免疫抑制作用。将近交系黑豚鼠(RT1a)的右后肢移植到Lewis大鼠(RT1l)上,并观察120天。共进行了88次移植。通过组织学和宏观观察对移植物的排斥反应进行评估。采用病理分级系统对排斥反应的严重程度进行评分。接受FK-506治疗数天的Lewis大鼠,通过与15-去氧精胍菌素联合治疗,肢体存活时间显著延长。组织学研究表明,除皮肤和骨髓出现排斥反应外,所有构成移植物的组织几乎均未出现排斥反应。这些结果表明,即使在停用两种药物后,骨骼、软骨和肌肉等组织在短期联合使用FK-506和15-去氧精胍菌素治疗后仍可在移植后存活。